APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pulmicort

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pulmicort Industry Growth and Trends Forecast to 2032

Report ID 17402989012 January 2026100 pages

Choose your research edition.

Industry ResearchPulmicort Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmicort Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pulmicort Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmicort Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmicort Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pulmicort market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pulmicort is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pulmicort is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmicort is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmicort include Teva, Shanghai Sine Promod, Sandoz, Mylan, Lunan Better Pharma, AstraZeneca, Synmosa Biopharma, Salix and Orion Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pulmicort market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pulmicort market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pulmicort market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pulmicort.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pulmicort market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pulmicort Market by Company

Teva

Shanghai Sine Promod

Sandoz

Mylan

Lunan Better Pharma

AstraZeneca

Synmosa Biopharma

Salix

Orion Corporation

Cosmo Pharmaceuticals

Cipla

Chiesi Farmaceutici

Pulmicort Segment by Type

Tablet and Capsule

Aerosols

Inhalation Powder

Injectable Suspension

Pulmicort Segment by Application

Inflammatory Bowel Disease Treatment

Respiratory Disease Treatment

Nose Disease Treatment

Others

Pulmicort Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmicort market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmicort and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmicort.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmicort manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pulmicort in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet and Capsule Table 2. Major Company of Aerosols Table 3. Major Company of Inhalation Powder Table 4. Major Company of Injectable Suspension Table 5. Global Pulmicort Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pulmicort Sales by Type (2021-2026) & (Units) Table 7. Global Pulmicort Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pulmicort Sales Market Share in Value by Type (2021-2026) Table 10. Global Pulmicort Price by Type (2021-2026) & (US$/Unit) Table 11. Global Pulmicort Sales by Type (2027-2032) & (Units) Table 12. Global Pulmicort Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pulmicort Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pulmicort Sales Market Share in Value by Type (2027-2032) Table 15. Global Pulmicort Price by Type (2027-2032) & (US$/Unit) Table 16. North America Pulmicort Sales by Type (2021-2026) & (Units) Table 17. North America Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pulmicort Sales by Type (2021-2026) & (Units) Table 19. Europe Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pulmicort Sales by Type (2021-2026) & (Units) Table 21. Asia-Pacific Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pulmicort Sales by Type (2021-2026) & (Units) Table 23. Latin America Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pulmicort Sales by Type (2021-2026) & (Units) Table 25. Middle East and Africa Pulmicort Sales by Type (2021-2026) & (US$ Million) Table 26. Pulmicort Industry Trends Table 27. Pulmicort Industry Drivers Table 28. Pulmicort Industry Opportunities and Challenges Table 29. Pulmicort Industry Restraints Table 30. Global Pulmicort Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pulmicort Revenue Market Share by Company (2021-2026) Table 32. Global Pulmicort Sales by Company (2021-2026) & (Units) Table 33. Global Pulmicort Sales Share by Company (2021-2026) Table 34. Global Pulmicort Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Pulmicort Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pulmicort Major Company Production Sites and Headquarters Table 37. Global Pulmicort Company, Product Type & Application Table 38. Global Pulmicort Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pulmicort by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pulmicort Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pulmicort Sales by Region (2021-2026) & (Units) Table 43. Global Pulmicort Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pulmicort Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pulmicort Sales Market Share in Value by Region (2021-2026) Table 46. Global Pulmicort Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Pulmicort Sales by Region (2027-2032) & (Units) Table 48. Global Pulmicort Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pulmicort Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pulmicort Sales Market Share in Value by Region (2027-2032) Table 51. Global Pulmicort Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Pulmicort Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pulmicort Sales by Application (2021-2026) & (Units) Table 54. Global Pulmicort Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pulmicort Sales Market Share in Value by Application (2021-2026) Table 57. Global Pulmicort Price by Application (2021-2026) & (US$/Unit) Table 58. Global Pulmicort Sales by Application (2027-2032) & (Units) Table 59. Global Pulmicort Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pulmicort Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pulmicort Sales Market Share in Value by Application (2027-2032) Table 62. Global Pulmicort Price by Application (2027-2032) & (US$/Unit) Table 63. North America Pulmicort Sales by Application (2021-2026) & (Units) Table 64. North America Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pulmicort Sales by Application (2021-2026) & (Units) Table 66. Europe Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pulmicort Sales by Application (2021-2026) & (Units) Table 68. Asia-Pacific Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pulmicort Sales by Application (2021-2026) & (Units) Table 70. Latin America Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pulmicort Sales by Application (2021-2026) & (Units) Table 72. Middle East and Africa Pulmicort Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pulmicort Product Portfolio Table 77. Teva Recent Development Table 78. Shanghai Sine Promod Company Information Table 79. Shanghai Sine Promod Business Overview Table 80. Shanghai Sine Promod Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Sine Promod Pulmicort Product Portfolio Table 82. Shanghai Sine Promod Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sandoz Pulmicort Product Portfolio Table 87. Sandoz Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Pulmicort Product Portfolio Table 92. Mylan Recent Development Table 93. Lunan Better Pharma Company Information Table 94. Lunan Better Pharma Business Overview Table 95. Lunan Better Pharma Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lunan Better Pharma Pulmicort Product Portfolio Table 97. Lunan Better Pharma Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AstraZeneca Pulmicort Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Synmosa Biopharma Company Information Table 104. Synmosa Biopharma Business Overview Table 105. Synmosa Biopharma Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Synmosa Biopharma Pulmicort Product Portfolio Table 107. Synmosa Biopharma Recent Development Table 108. Salix Company Information Table 109. Salix Business Overview Table 110. Salix Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Salix Pulmicort Product Portfolio Table 112. Salix Recent Development Table 113. Orion Corporation Company Information Table 114. Orion Corporation Business Overview Table 115. Orion Corporation Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Orion Corporation Pulmicort Product Portfolio Table 117. Orion Corporation Recent Development Table 118. Cosmo Pharmaceuticals Company Information Table 119. Cosmo Pharmaceuticals Business Overview Table 120. Cosmo Pharmaceuticals Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Cosmo Pharmaceuticals Pulmicort Product Portfolio Table 122. Cosmo Pharmaceuticals Recent Development Table 123. Cipla Company Information Table 124. Cipla Business Overview Table 125. Cipla Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Cipla Pulmicort Product Portfolio Table 127. Cipla Recent Development Table 128. Chiesi Farmaceutici Company Information Table 129. Chiesi Farmaceutici Business Overview Table 130. Chiesi Farmaceutici Pulmicort Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Chiesi Farmaceutici Pulmicort Product Portfolio Table 132. Chiesi Farmaceutici Recent Development Table 133. North America Pulmicort Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 134. North America Pulmicort Sales by Country (2021-2026) & (Units) Table 135. North America Pulmicort Sales Market Share by Country (2021-2026) Table 136. North America Pulmicort Sales Forecast by Country (2027-2032) & (Units) Table 137. North America Pulmicort Sales Market Share Forecast by Country (2027-2032) Table 138. North America Pulmicort Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Pulmicort Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Pulmicort Market Share by Country (2021-2026) Table 141. North America Pulmicort Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Pulmicort Market Share Forecast by Country (2027-2032) Table 143. Europe Pulmicort Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 144. Europe Pulmicort Sales by Country (2021-2026) & (Units) Table 145. Europe Pulmicort Sales Market Share by Country (2021-2026) Table 146. Europe Pulmicort Sales Forecast by Country (2027-2032) & (Units) Table 147. Europe Pulmicort Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Pulmicort Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Pulmicort Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Pulmicort Market Share by Country (2021-2026) Table 151. Europe Pulmicort Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Pulmicort Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Pulmicort Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Pulmicort Sales by Country (2021-2026) & (Units) Table 155. Asia-Pacific Pulmicort Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Pulmicort Sales Forecast by Country (2027-2032) & (Units) Table 157. Asia-Pacific Pulmicort Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Pulmicort Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Pulmicort Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Pulmicort Market Share by Country (2021-2026) Table 161. Asia-Pacific Pulmicort Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Pulmicort Market Share Forecast by Country (2027-2032) Table 163. Latin America Pulmicort Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 164. Latin America Pulmicort Sales by Country (2021-2026) & (Units) Table 165. Latin America Pulmicort Sales Market Share by Country (2021-2026) Table 166. Latin America Pulmicort Sales Forecast by Country (2027-2032) & (Units) Table 167. Latin America Pulmicort Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Pulmicort Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Pulmicort Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Pulmicort Market Share by Country (2021-2026) Table 171. Latin America Pulmicort Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Pulmicort Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Pulmicort Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Pulmicort Sales by Country (2021-2026) & (Units) Table 175. Middle East and Africa Pulmicort Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Pulmicort Sales Forecast by Country (2027-2032) & (Units) Table 177. Middle East and Africa Pulmicort Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Pulmicort Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Pulmicort Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Pulmicort Market Share by Country (2021-2026) Table 181. Middle East and Africa Pulmicort Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Pulmicort Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Pulmicort Distributors List Table 186. Pulmicort Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Pulmicort Image Figure 2. Global Pulmicort Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmicort Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmicort Sales (2021-2032) & (Units) Figure 5. Tablet and Capsule Image Figure 6. Global Tablet and Capsule Sales YoY Growth (2021-2032) & (Units) Figure 7. Aerosols Image Figure 8. Global Aerosols Sales YoY Growth (2021-2032) & (Units) Figure 9. Inhalation Powder Image Figure 10. Global Inhalation Powder Sales YoY Growth (2021-2032) & (Units) Figure 11. Injectable Suspension Image Figure 12. Global Injectable Suspension Sales YoY Growth (2021-2032) & (Units) Figure 13. Global Pulmicort Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pulmicort Market Share by Type 2025 VS 2032 Figure 15. North America Pulmicort Sales Market Share in Volume by Type in 2025 Figure 16. North America Pulmicort Sales Market Share in Value by Type in 2025 Figure 17. Europe Pulmicort Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pulmicort Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pulmicort Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pulmicort Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pulmicort Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pulmicort Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pulmicort Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pulmicort Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pulmicort Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Inflammatory Bowel Disease Treatment Image Figure 28. Global Inflammatory Bowel Disease Treatment Sales YoY Growth (2021-2032) & (Units) Figure 29. Respiratory Disease Treatment Image Figure 30. Global Respiratory Disease Treatment Sales YoY Growth (2021-2032) & (Units) Figure 31. Nose Disease Treatment Image Figure 32. Global Nose Disease Treatment Sales YoY Growth (2021-2032) & (Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 35. Global Pulmicort Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pulmicort Market Share by Application 2025 VS 2032 Figure 37. North America Pulmicort Sales Market Share in Volume by Application in 2025 Figure 38. North America Pulmicort Sales Market Share in Value by Application in 2025 Figure 39. Europe Pulmicort Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pulmicort Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pulmicort Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pulmicort Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pulmicort Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pulmicort Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pulmicort Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pulmicort Sales Market Share in Value by Application in 2025 Figure 47. North America Pulmicort Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. North America Pulmicort Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pulmicort Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pulmicort Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pulmicort Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Europe Pulmicort Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pulmicort Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pulmicort Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pulmicort Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Asia-Pacific Pulmicort Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pulmicort Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pulmicort Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pulmicort Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Latin America Pulmicort Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pulmicort Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pulmicort Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pulmicort Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Middle East and Africa Pulmicort Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pulmicort Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pulmicort Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pulmicort Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pulmicort Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet and Capsule
  • Aerosols
  • Inhalation Powder
  • Injectable Suspension
Applications
  • Inflammatory Bowel Disease Treatment
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Others
Companies covered
  • Teva
  • Shanghai Sine Promod
  • Sandoz
  • Mylan
  • Lunan Better Pharma
  • AstraZeneca
  • Synmosa Biopharma
  • Salix
  • Orion Corporation
  • Cosmo Pharmaceuticals
  • Cipla
  • Chiesi Farmaceutici

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmicort Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pulmicort Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pulmicort Market by Type
  6. 1.3.1 Tablet and Capsule
  7. 1.3.2 Aerosols
  8. 1.3.3 Inhalation Powder
  9. 1.3.4 Injectable Suspension
  10. 1.4 Global Pulmicort Market Size by Type
  11. 1.4.1 Global Pulmicort Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pulmicort Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pulmicort Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pulmicort Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pulmicort Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pulmicort Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pulmicort Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pulmicort Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pulmicort Industry Trends
  2. 2.2 Pulmicort Industry Drivers
  3. 2.3 Pulmicort Industry Opportunities and Challenges
  4. 2.4 Pulmicort Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pulmicort Revenue (2021-2026)
  2. 3.2 Global Top Players by Pulmicort Sales (2021-2026)
  3. 3.3 Global Top Players by Pulmicort Price (2021-2026)
  4. 3.4 Global Pulmicort Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmicort Major Company Production Sites & Headquarters
  6. 3.6 Global Pulmicort Company, Product Type & Application
  7. 3.7 Global Pulmicort Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmicort Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmicort Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmicort Tier 1, Tier 2, and Tier 3
4 Pulmicort Regional Status and Outlook
  1. 4.1 Global Pulmicort Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pulmicort Historic Market Size by Region
  3. 4.2.1 Global Pulmicort Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pulmicort Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pulmicort Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pulmicort Forecasted Market Size by Region
  7. 4.3.1 Global Pulmicort Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pulmicort Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pulmicort Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pulmicort by Application
  1. 5.1 Pulmicort Market by Application
  2. 5.1.1 Inflammatory Bowel Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Nose Disease Treatment
  5. 5.1.4 Others
  6. 5.2 Global Pulmicort Market Size by Application
  7. 5.2.1 Global Pulmicort Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pulmicort Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pulmicort Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pulmicort Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pulmicort Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pulmicort Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pulmicort Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pulmicort Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pulmicort Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Shanghai Sine Promod
  8. 6.2.1 Shanghai Sine Promod Company Information
  9. 6.2.2 Shanghai Sine Promod Business Overview
  10. 6.2.3 Shanghai Sine Promod Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Sine Promod Pulmicort Product Portfolio
  12. 6.2.5 Shanghai Sine Promod Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Pulmicort Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Pulmicort Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Lunan Better Pharma
  26. 6.5.1 Lunan Better Pharma Company Information
  27. 6.5.2 Lunan Better Pharma Business Overview
  28. 6.5.3 Lunan Better Pharma Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lunan Better Pharma Pulmicort Product Portfolio
  30. 6.5.5 Lunan Better Pharma Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Pulmicort Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Synmosa Biopharma
  38. 6.7.1 Synmosa Biopharma Company Information
  39. 6.7.2 Synmosa Biopharma Business Overview
  40. 6.7.3 Synmosa Biopharma Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Synmosa Biopharma Pulmicort Product Portfolio
  42. 6.7.5 Synmosa Biopharma Recent Developments
  43. 6.8 Salix
  44. 6.8.1 Salix Company Information
  45. 6.8.2 Salix Business Overview
  46. 6.8.3 Salix Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Salix Pulmicort Product Portfolio
  48. 6.8.5 Salix Recent Developments
  49. 6.9 Orion Corporation
  50. 6.9.1 Orion Corporation Company Information
  51. 6.9.2 Orion Corporation Business Overview
  52. 6.9.3 Orion Corporation Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Orion Corporation Pulmicort Product Portfolio
  54. 6.9.5 Orion Corporation Recent Developments
  55. 6.10 Cosmo Pharmaceuticals
  56. 6.10.1 Cosmo Pharmaceuticals Company Information
  57. 6.10.2 Cosmo Pharmaceuticals Business Overview
  58. 6.10.3 Cosmo Pharmaceuticals Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cosmo Pharmaceuticals Pulmicort Product Portfolio
  60. 6.10.5 Cosmo Pharmaceuticals Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Pulmicort Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Chiesi Farmaceutici
  68. 6.12.1 Chiesi Farmaceutici Company Information
  69. 6.12.2 Chiesi Farmaceutici Business Overview
  70. 6.12.3 Chiesi Farmaceutici Pulmicort Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chiesi Farmaceutici Pulmicort Product Portfolio
  72. 6.12.5 Chiesi Farmaceutici Recent Developments
7 North America by Country
  1. 7.1 North America Pulmicort Sales by Country
  2. 7.1.1 North America Pulmicort Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pulmicort Sales by Country (2021-2026)
  4. 7.1.3 North America Pulmicort Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pulmicort Market Size by Country
  6. 7.2.1 North America Pulmicort Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pulmicort Market Size by Country (2021-2026)
  8. 7.2.3 North America Pulmicort Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pulmicort Sales by Country
  2. 8.1.1 Europe Pulmicort Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pulmicort Sales by Country (2021-2026)
  4. 8.1.3 Europe Pulmicort Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pulmicort Market Size by Country
  6. 8.2.1 Europe Pulmicort Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pulmicort Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pulmicort Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pulmicort Sales by Country
  2. 9.1.1 Asia-Pacific Pulmicort Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pulmicort Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pulmicort Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pulmicort Market Size by Country
  6. 9.2.1 Asia-Pacific Pulmicort Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pulmicort Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pulmicort Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pulmicort Sales by Country
  2. 10.1.1 South America Pulmicort Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pulmicort Sales by Country (2021-2026)
  4. 10.1.3 South America Pulmicort Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pulmicort Market Size by Country
  6. 10.2.1 South America Pulmicort Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pulmicort Market Size by Country (2021-2026)
  8. 10.2.3 South America Pulmicort Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pulmicort Sales by Country
  2. 11.1.1 Middle East and Africa Pulmicort Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pulmicort Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pulmicort Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pulmicort Market Size by Country
  6. 11.2.1 Middle East and Africa Pulmicort Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pulmicort Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pulmicort Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pulmicort Value Chain Analysis
  2. 12.1.1 Pulmicort Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pulmicort Production Mode & Process
  7. 12.2 Pulmicort Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pulmicort Distributors
  10. 12.2.3 Pulmicort Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst